Credit Suisse’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-6,893,749
| Closed | -$685M | – | 4483 |
|
|
2019
Q3 | $685M | Sell |
6,893,749
-353,189
| -5% | -$33.6M | 0.58% | 20 |
|
|
2019
Q2 | $670M | Buy |
7,246,938
+3,091,495
| +74% | +$294M | 0.59% | 17 |
|
|
2019
Q1 | $392M | Buy |
4,155,443
+2,133,985
| +106% | +$187M | 0.36% | 38 |
|
|
2018
Q4 | $130M | Buy |
2,021,458
+271,079
| +15% | +$20M | 0.13% | 140 |
|
|
2018
Q3 | $157M | Buy |
1,750,379
+144,788
| +9% | +$12.8M | 0.14% | 127 |
|
|
2018
Q2 | $128M | Sell |
1,605,591
-543,455
| -25% | -$45.1M | 0.13% | 142 |
|
|
2018
Q1 | $192M | Sell |
2,149,046
-81,649
| -4% | -$7.84M | 0.18% | 99 |
|
|
2017
Q4 | $233M | Buy |
2,230,695
+297,148
| +15% | +$33.5M | 0.21% | 87 |
|
|
2017
Q3 | $282M | Sell |
1,933,547
-165,567
| -8% | -$22.6M | 0.27% | 61 |
|
|
2017
Q2 | $273M | Sell |
2,099,114
-211,438
| -9% | -$25.9M | 0.27% | 67 |
|
|
2017
Q1 | $288M | Buy |
2,310,552
+288,753
| +14% | +$34.6M | 0.26% | 66 |
|
|
2016
Q4 | $234M | Sell |
2,021,799
-691,710
| -25% | -$77M | 0.23% | 77 |
|
|
2016
Q3 | $284M | Buy |
2,713,509
+305,737
| +13% | +$33.1M | 0.27% | 60 |
|
|
2016
Q2 | $237M | Sell |
2,407,772
-262,299
| -10% | -$27.1M | 0.26% | 66 |
|
|
2016
Q1 | $267M | Sell |
2,670,071
-254,840
| -9% | -$26.2M | 0.32% | 57 |
|
|
2015
Q4 | $350M | Sell |
2,924,911
-171,950
| -6% | -$19.9M | 0.4% | 37 |
|
|
2015
Q3 | $335M | Sell |
3,096,861
-232,123
| -7% | -$28.8M | 0.4% | 38 |
|
|
2015
Q2 | $385M | Buy |
3,328,984
+402,894
| +14% | +$46.1M | 0.38% | 42 |
|
|
2015
Q1 | $337M | Sell |
2,926,090
-266,873
| -8% | -$31.9M | 0.34% | 49 |
|
|
2014
Q4 | $357M | Sell |
3,192,963
-285,054
| -8% | -$30.1M | 0.32% | 54 |
|
|
2014
Q3 | $330M | Buy |
3,478,017
+623,090
| +22% | +$56.2M | 0.27% | 68 |
|
|
2014
Q2 | $245M | Sell |
2,854,927
-71,647
| -2% | -$5.45M | 0.2% | 89 |
|
|
2014
Q1 | $204M | Sell |
2,926,574
-230,058
| -7% | -$18.2M | 0.2% | 92 |
|
|
2013
Q4 | $267M | Buy |
3,156,632
+459,134
| +17% | +$36.3M | 0.24% | 70 |
|
|
2013
Q3 | $208M | Sell |
2,697,498
-431,032
| -14% | -$30.2M | 0.21% | 81 |
|
|
2013
Q2 | $183M | Buy |
+3,128,530
| New | +$188M | 0.18% | 89 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Credit Suisse's CELG Position: Q4 2019 in Review
Credit Suisse sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 6,893,749 shares — an estimated $685M sold.
Credit Suisse first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $685M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Credit Suisse reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Credit Suisse sold 6,893,749 Celgene Corp shares in Q4 2019, an estimated $685M.
- Credit Suisse first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Credit Suisse's Celgene Corp position peaked at $685M in Q3 2019.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Credit Suisse's 13F filing for Q4 2019, filed 12 Feb 2020.